Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569894 · ClinicalTrials.gov registry record
A Post Marking Study to Evaluate the Safety of FluMist in Children
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 29,296
- Enrollment target
NCT00569894: Completed study, sponsored by MedImmune.
NCT00569894 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 29,296 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00569894 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 29,296 participants
- Enrollment target
Study Summary
To assess the safety of FluMist vaccination
Interventions
- BIOLOGICAL FLuMist
- BIOLOGICAL TIV (Injection)
- OTHER Unvaccinated Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29,296 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-06 |
What the finished NCT00569894 record still lists
NCT00569894 is an observational study that tracks outcomes without assigning an intervention. Its 29,296 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which FLuMist is the first listed.
NCT00569894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00569894 about?
NCT00569894 is a clinical study titled "A Post Marking Study to Evaluate the Safety of FluMist in Children". To assess the safety of FluMist vaccination
What is the current status of trial NCT00569894?
This trial is currently completed. The enrollment target is 29,296 participants. The study started on 2007-10. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00569894?
The interventions under investigation include: FLuMist (BIOLOGICAL), TIV (Injection) (BIOLOGICAL), Unvaccinated Control (OTHER).
Who is sponsoring clinical trial NCT00569894?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia